Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Fluphenazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 3/20 | 0.98 |
| ▸ | LMNA | P02545 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 1.00 |
| ▸ | USP2 | O75604 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | RAD52 | P43351 | 4/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 3/20 | 1.00 |
| ▸ | GMNN | O75496 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | UBE2N | P61088 | 2/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluphenazine SCHEMBL2560022 | 1.00 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL1496274 | 1.00 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL29860638 | 1.00 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL30390918 | 1.00 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL41635 | 1.00 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL7194249 | 0.99 | LMNA (0.98) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL29388890 | 0.99 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL29354183 | 0.99 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL5072860 | 0.99 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 | |
| Fluphenazine SCHEMBL19221 | 0.99 | LMNA (1.00) | LMNAMAPTSMN1; SMN2NPSR1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6294 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4602178-A1 | RESPIRATION OF NANOPARTICLES BY ELECTROGENIC BACTERIA FOR PHOTO-CATALYTIC HYDROGEN EVOLUTION | University of Rochester (US) | 2025-08-20 | — | — | EP | claimed |
| US-12312628-B2 | Metabolic control over organometallic catalysts using electroactive bacteria | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-05-27 | — | — | US | claimed |
| WO-2025078446-A1 | MICROFLUIDIC DEVICE AND METHOD THEREOF FOR RAPID ASSAYS IN SAMPLES | OLSSON CARL (SE) | 2025-04-17 | — | — | WO | claimed |
| US-20250090501-A1 | METHODS OF TREATING GUT MOTILITY DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-20 | — | — | US | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| EP-4460293-A2 | METHODS OF TREATING GUT MOTILITY DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-13 | — | — | EP | claimed |
| CN-114983866-B | Reticular macromolecule sun-proof film cosmetic composition | 广州科创材料科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| WO-2024081205-A1 | RESPIRATION OF NANOPARTICLES BY ELECTROGENIC BACTERIA FOR PHOTO-CATALYTIC HYDROGEN EVOLUTION | UNIVERSITY OF ROCHESTER (US) | 2024-04-18 | — | — | WO | claimed |
| CN-115947460-B | Preparation method and application of slow-release carbon source material matched with physiological characteristics of functional microorganisms | 哈尔滨工业大学 | 2024-01-12 | — | — | CN | claimed |
| EP-0741570-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1996-11-13 | — | — | EP | claimed |
| WO-1995020387-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1995-08-03 | — | — | WO | claimed |
| EP-0413771-B1 | COMPOSITION FOR THE TREATMENT OF SCHIZOPHRENIA | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 1994-11-09 | — | — | EP | claimed |
| US-4938758-A | Anti-pathogenic blood collection system and method | AL SIOUFI HABIB (US) | 1990-07-03 | — | — | US | claimed |
| EP-0180364-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PHENOTHIAZINES | RECKITT AND COLMAN PRODUCTS LIMITED (GB) | 1990-03-07 | — | — | EP | claimed |
| EP-0263873-A4 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD. | AL-SIOUFI HABIB | 1989-07-11 | — | — | EP | claimed |
| EP-0263873-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL-SIOUFI, Habib (US) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006119-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL SIOUFI HABIB | 1987-10-22 | — | — | WO | claimed |
| EP-0189861-A2 | Percutaneous absorption accelerator for ionic water-soluble medicine | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1986-08-06 | — | — | EP | claimed |
| EP-0180364-A2 | Pharmaceutical compositions containing phenothiazines | RECKITT AND COLMAN PRODUCTS LIMITED (GB) | 1986-05-07 | — | — | EP | claimed |